Total hip replacement and antithrombotic prophylaxis.
British orthopaedic surgeons were surveyed to assess the practice of prophylaxis against thromboembolism in patients undergoing total hip replacements. Of 690 surgeons, 348 (50.4%) do not routinely use pharmacological prophylaxis (190 use no prophylaxis while 158 use a mechanical form of prophylaxis), 289 (41.9%) surgeons use a single pharmacological agent (with or without a mechanical form of prophylaxis), and the remaining 53 (7.7%) use two or more pharmacological agents.
Brenkel
I J
IJ
St James's University Hospital, Leeds.
Clancy
M J
MJ
D000991:Antithrombins / Q000627:therapeutic use*; D006622:Hip Prosthesis; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D011795:Surveys and Questionnaires; D013923:Thromboembolism / Q000517:prevention & control*; D006113:United Kingdom
D000991:Antithrombins